Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow | Key Levels 29 June 2026

  • June 28, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
Nifty Pharma Prediction for Tomorrow
 

Nifty Pharma 24,969.50 (-0.20%) on 25 June 2026. Mkt closed 26 June 2026. Nifty 24,056.00. VIX 13.05. No expiry 29 June 2026. Triple expiry 30 June 2026. S1:24,850. R1:25,200.

The nifty pharma prediction for tomorrow for 29 June 2026 is based on the last close of 24,969.50 (-49.45, -0.20%) on 25 June 2026. Indian markets were closed on 26 June 2026 (Friday) on account of Muharram, making Monday 29 June 2026 the next trading session after a three-day gap. The Nifty 50 last closed at 24,056.00 with VIX at 13.05. Nifty Pharma fell -0.20% as mild defensive-to-cyclical rotation reduced exposure to pharma names while Auto sector outperformed sharply. An important context for the nifty pharma prediction for tomorrow: Monday 29 June 2026 has no F&O expiry of any kind. The key upcoming event is Tuesday 30 June 2026, which is a triple expiry day: Nifty 50 weekly, Nifty 50 monthly, and Bank Nifty monthly all expire together. Monday’s nifty pharma prediction for tomorrow session will see institutional pre-positioning ahead of Tuesday’s settlement.

Ankit Jaiswal, Senior Research Analyst at Univest, and Associate Director Kunal Singla present the nifty pharma prediction for tomorrow for Monday based on 25 June 2026’s data and the extended weekend gap context.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Nifty Pharma Prediction for Tomorrow: Last Close and Gap Context
  • Nifty Pharma Prediction for Tomorrow: Key Levels
  • Nifty Pharma F&O Context for 29 June 2026
  • Global and Macro Cues for Nifty Pharma Prediction for Tomorrow
  • Trading Strategy: Nifty Pharma Prediction for Tomorrow
  • What Data Indicates for nifty pharma prediction for tomorrow
  • Risks to Nifty Pharma Prediction for Tomorrow
  • Stocks to Watch Tomorrow, 29 June 2026
  • Conclusion
  • FAQs
    • What is the nifty tomorrow Monday view, 29 June 2026?
    • Is there F&O expiry for Nifty Pharma tomorrow 29 June 2026?
    • What is Nifty Pharma support for tomorrow 29 June 2026?
    • Why is there a three-day gap in nifty tomorrow Monday view?
    • What stocks to watch alongside nifty tomorrow Monday view?

Nifty Pharma Prediction for Tomorrow: Last Close and Gap Context

  • Last Close (25 June 2026): Nifty Pharma settled at 24,969.50 (-49.45, -0.20%). Nifty Pharma fell -0.20% as mild profit-booking in defensive pharma occurred while cyclicals like Auto (+2.25%) dominated Thursday’s session. This is the base for the nifty pharma prediction for tomorrow heading into Monday.
  • Three-Day Gap: No Indian market trading on 26 June 2026 (Muharram). The nifty pharma prediction for tomorrow carries Iran-US talk weekend outcome, US Friday close, and Asian Monday morning opens as unabsorbed inputs. Check GIFT Nifty between 7:00 and 9:15 AM on 29 June 2026 before placing Nifty Pharma positions.
  • Monday No Expiry: 29 June 2026 has no F&O expiry. The nifty pharma prediction for tomorrow session is more purely directional and macro-driven than the expiry-heavy sessions of last week. No direct Nifty Pharma F&O expiry Monday. Tuesday pre-positioning may see some rotation from defensive pharma into Nifty 50 monthly positions being built.

Nifty Pharma Prediction for Tomorrow: Key Levels

Trend: Cautiously Bearish | Support 24,850 | Resistance 25,200

Level Nifty Pharma
Support 1 24,850
Support 2 24,700
Resistance 1 25,200
Resistance 2 25,400

The nifty pharma prediction for tomorrow from Ankit Jaiswal places 24,850 as the immediate support for Monday. A sustained move below 24,850 in the nifty pharma prediction for tomorrow targets 24,700 as the next support. The three-day gap from 25 June 2026’s close means the nifty pharma prediction for tomorrow opening level on Monday may differ significantly from 24,969.50 depending on GIFT Nifty and Iran-US weekend news. Use limit orders rather than market orders for the nifty pharma prediction for tomorrow at Monday’s open.

Nifty Pharma F&O Context for 29 June 2026

  • No Nifty Pharma Expiry Monday: 29 June 2026 has no direct F&O expiry for Nifty Pharma. The nifty pharma prediction for tomorrow is therefore driven by macro factors and global cues rather than expiry pin-risk on Monday.
  • Tuesday 30 June 2026 Triple Expiry: Nifty 50 weekly+monthly and the Bank Nifty monthly all expire on Tuesday 30 June 2026. Pre-expiry positioning for this on Monday will create institutional flow momentum that shapes the nifty pharma prediction for tomorrow direction through the session.
  • July Series Opening: Fresh July F&O series OI begins building from Monday. Initial Put OI concentration in Nifty Pharma’s related contracts near 24,700 would confirm the nifty pharma prediction for tomorrow structural floor.

Global and Macro Cues for Nifty Pharma Prediction for Tomorrow

  • Iran-US Weekend Outcome: The nifty pharma prediction for tomorrow swing factor for Monday. A confirmed deal improves the nifty pharma prediction for tomorrow for crude-linked and risk-on sectors; a collapse reverses sentiment and challenges 24,850 support at open.
  • GIFT Nifty Monday Morning: Check between 7:00 and 9:15 AM on 29 June 2026. GIFT Nifty above 24,100 supports the nifty pharma prediction for tomorrow positive scenario; below 23,900 signals caution for the nifty pharma prediction for tomorrow at Monday’s open.
  • VIX at 13.05: Multi-week low VIX entering the three-day gap reduces probability of extreme intraday moves in the nifty pharma prediction for tomorrow on Monday, unless a major weekend macro shock occurs.

Track Nifty Pharma Live Data on Univest Before Tomorrow’s Open

Trading Strategy: Nifty Pharma Prediction for Tomorrow

  1. GIFT Nifty Before Entry: Confirm Monday’s opening direction from GIFT Nifty between 7:00 and 9:15 AM before placing any nifty pharma prediction for tomorrow positions.
  2. 24,850 as Pivot: The nifty pharma prediction for tomorrow is constructive above 24,850 and cautious below. Buy dips to 24,850 with positive GIFT Nifty, targeting 25,200 with stop at 24,700.
  3. Tuesday Pre-Positioning: Institutions building Tuesday expiry positions on Monday may create directional momentum in the nifty pharma prediction for tomorrow. Follow the pre-expiry flow direction rather than fading it.
  4. Use Limit Orders: The three-day gap creates higher opening gap risk for the nifty pharma prediction for tomorrow. Avoid market orders at Monday’s 9:15 AM open. Wait for the 9:30 AM opening range to settle before entering the nifty pharma prediction for tomorrow.

What Data Indicates for nifty pharma prediction for tomorrow

VIX at 13.05 on 25 June 2026 is the most constructive signal for the nifty pharma prediction for tomorrow. Multi-week low VIX entering a three-day gap supports range-bound to positive outcomes for the nifty pharma prediction for tomorrow assuming no major weekend macro shock. Ankit Jaiswal notes that the nifty pharma prediction for tomorrow’s 24,969.50 close on 25 June 2026 combined with Monday’s no-expiry environment creates one of the cleanest directional setups of the week for the nifty pharma prediction for tomorrow.

Kunal Singla observes that Tuesday 30 June 2026’s triple expiry creates structural demand for pre-positioning on Monday. Institutions building Nifty 50 monthly and Bank Nifty monthly positions will tend to support the broader market, which in turn supports the nifty pharma prediction for tomorrow above 24,850 floor on Monday.

Download the Univest iOS App or Univest Android App to get live Nifty Pharma updates and expert Monday market research.

Risks to Nifty Pharma Prediction for Tomorrow

  • Iran Talks Collapse: A weekend breakdown would gap the nifty pharma prediction for tomorrow below 24,700 at Monday’s open, invalidating pre-set support levels.
  • USFDA Risk: Any USFDA warning letter or import alert for a major pharma company over the weekend would sharply worsen the nifty pharma prediction for tomorrow below 24,850.
  • Three-Day Gap Amplification: Three days without Indian market trading amplifies opening gap risk for the nifty pharma prediction for tomorrow. Any major global development between Thursday close and Monday open will be fully priced in at the nifty tomorrow Monday view Monday opening.

Stocks to Watch Tomorrow, 29 June 2026

Ankit Jaiswal and Kunal Singla of Univest flag three stocks for Monday 29 June 2026. While Monday has no F&O expiry, Tuesday 30 June 2026 is a triple expiry day: Nifty 50 weekly, Nifty 50 monthly, and Bank Nifty monthly all settle together. Monday’s session will see institutional pre-positioning for this event.

Stock Last Close (25 June 2026) Entry Zone Target Stop Loss
ICICI Bank Rs 1,387.50 Rs 1,382 to Rs 1,392 Rs 1,412 to Rs 1,420 Rs 1,368
HDFC Bank Rs 796.30 Rs 793 to Rs 799 Rs 812 to Rs 818 Rs 783
Reliance Industries Rs 1,318.10 Rs 1,314 to Rs 1,320 Rs 1,338 to Rs 1,345 Rs 1,300

ICICI Bank last closed at Rs 1,387.50 (+1.01%) on 25 June 2026, the standout banking performer. Jaiswal flags entry Rs 1,382 to Rs 1,392 targeting Rs 1,412 with stop Rs 1,368. HDFC Bank at Rs 796.30 is the largest Nifty 50 and Sensex constituent. With Tuesday 30 June 2026 bringing Nifty 50 monthly expiry, Singla flags HDFC Bank pre-expiry positioning as a specific driver. Entry Rs 793 to Rs 799, target Rs 812, stop Rs 783. Reliance Industries at Rs 1,318.10 benefits from any Iran-deal crude resolution. Entry Rs 1,314 to Rs 1,320, target Rs 1,338, stop Rs 1,300.

Conclusion

The nifty tomorrow Monday view for 29 June 2026 is cautiously bearish with support at 24,850 and resistance at 25,200. Ankit Jaiswal notes that VIX at 13.05 and Monday’s no-expiry environment provide a clean directional backdrop for the nifty tomorrow Monday view. The three-day gap from 25 June 2026 (market closed 26 June 2026, Muharram) requires GIFT Nifty confirmation before entering the nifty tomorrow Monday view. Tuesday 30 June 2026’s triple expiry pre-positioning will shape Monday’s nifty tomorrow Monday view momentum throughout the session.

Disclaimer: Data and figures are sourced from publicly available information. Please verify with NSE (nseindia.com), BSE (bseindia.com) and MCX (mcxindia.com) before investing. Investments are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What is the nifty tomorrow Monday view, 29 June 2026?

Ans. The nifty tomorrow Monday view is cautiously bearish for 29 June 2026. Nifty Pharma last closed at 24,969.50 (-0.20%) on 25 June 2026. Market was closed 26 June 2026 (Muharram). Support 24,850, resistance 25,200. No F&O expiry Monday. Iran-US weekend outcome is the primary swing factor.

Is there F&O expiry for Nifty Pharma tomorrow 29 June 2026?

Ans. No. Monday 29 June 2026 has no F&O expiry for any index. The Sensex weekly and monthly both expired on Thursday 25 June 2026. The next expiry is Tuesday 30 June 2026: Nifty 50 weekly+monthly+Bank Nifty monthly triple expiry. Monday is a pre-positioning day for this event.

What is Nifty Pharma support for tomorrow 29 June 2026?

Ans. Support at 24,850 and 24,700 for the nifty tomorrow Monday view. Resistance at 25,200 and 25,400. The three-day gap from 25 June 2026 means Monday’s opening may gap beyond these levels on Iran-US news. Check GIFT Nifty before entry.

Why is there a three-day gap in nifty tomorrow Monday view?

Ans. Indian markets were closed on 26 June 2026 (Friday) due to Muharram. The nifty tomorrow Monday view is based on 25 June 2026’s close. This creates a three-day gap (Thursday to Monday) where US Friday close, Iran-US talk outcome, and Asian Monday opens all feed into the nifty tomorrow Monday view via GIFT Nifty.

What stocks to watch alongside nifty tomorrow Monday view?

Ans. ICICI Bank (entry Rs 1,382 to Rs 1,392, target Rs 1,412), HDFC Bank (entry Rs 793 to Rs 799, target Rs 812), and Reliance (entry Rs 1,314 to Rs 1,320, target Rs 1,338) are Monday’s key picks.



Prediction for tomorrow
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply